{"id":107870,"date":"2021-02-24T15:51:46","date_gmt":"2021-02-24T15:51:46","guid":{"rendered":"https:\/\/fin2me.com\/?p=107870"},"modified":"2021-02-24T15:51:46","modified_gmt":"2021-02-24T15:51:46","slug":"major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/","title":{"rendered":"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds"},"content":{"rendered":"<ul>\n<li>More than three quarters of people in the U.K. now say they are &quot;very likely&quot; to have a coronavirus vaccine, a survey by the University of Oxford has found, up from 50% among the same group of survey respondents five months ago.<\/li>\n<li>The study, part of the University of Oxford-funded research project &#x27;Coping with COVID-19&#x27;,\u00a0was\u00a0conducted on a\u00a0representative sample of\u00a0over 1,600\u00a0U.K.\u00a0adults using the polling company YouGov.<\/li>\n<\/ul>\n<p>LONDON \u2014 More than three quarters of people in the U.K. now say they are &quot;very likely&quot; to have a coronavirus vaccine, a survey by the University of Oxford has found, up from 50% among the same group of survey respondents five months ago.<\/p>\n<p>The study, part of the University of Oxford-funded research project<strong> &#x27;<\/strong>Coping with COVID-19&#x27;,\u00a0was\u00a0conducted on a\u00a0representative sample of\u00a0over 1,600\u00a0U.K.\u00a0adults using the polling company YouGov.\u00a0<\/p>\n<p>It found that the percentage of people who are &quot;likely&quot; or &quot;very likely&quot; to take the vaccine has increased to 87% from 78% since the sampling of respondents last October.<\/p>\n<p>It found that age remains a strong predictor of willingness to take the vaccine with the\u00a050-59 age group now much more positive about the vaccine since October.<\/p>\n<p>There is a group of around\u00a07% of the population who remain &quot;very unlikely&quot; to take the vaccine\u00a0and this has not shifted greatly, the study said.<\/p>\n<p>The survey of 1,200 UK residents, contacted in early October 2020 and again in the first week of February 2021, showed strong relationships between political attitudes and the intention to accept the vaccine, however, and that\u00a0important gaps remain, driven by income and ethnicity.\u00a0\u00a0<\/p>\n<p>Co-authored by scholars from the University of Oxford, London School of Economics, and University College London, the study found that people on lower incomes\u00a0are,\u00a0on average,\u00a0much\u00a0less willing to take the vaccine.\u00a0It also found that ethnic minority participants&#x27; opinion of the vaccine had edged slightly in favor of the shot, but still trailed the white population represented in the survey.<\/p>\n<p>The U.K.&#x27;s vaccination rollout began in December, with priority given to the elderly, care home residents and staff, and health care workers. The nationwide vaccination program has been seen as a success so far, with the rollout now extending to more priority groups in younger age brackets, and those deemed clinically vulnerable. As of Monday, almost 18 million people have received their first dose of a coronavirus vaccine.<\/p>\n<p>Government officials have expressed concern over vaccine hesitancy among some key groups, however, including care home workers and some ethnic minorities.<\/p>\n<p>Barriers to vaccine uptake can include a perception of risk, low confidence in the vaccine, distrust in the medical establishment and a lack of endorsement or communication from trusted providers and community leaders, the government said in a recent report. It has sought to tackle vaccine hesitancy by engaging faith leaders and local medical practitioners that can easily engage with their local communities and encourage vaccine take-up.<\/p>\n<p>However, one&#x27;s political persuasion was found to affect vaccine acceptance too, according to the Oxford study, including whether respondents voted for Brexit or not.\u00a0The study found &quot;Remainers,&quot; those who voted for the U.K. to stay in the EU,\u00a0are 7 percentage points more likely to be willing to take the vaccine than &quot;Leavers,&quot; or those who did not vote in the 2016 referendum.\u00a0<\/p>\n<p>People\u00a0who voted for the Brexit party or Green in 2019 \u2014 and especially those who did not vote at all \u2014 were found to be the\u00a0least willing\u00a0to take the vaccine, with supporters of the Scottish National Party\u00a0and Liberal voters most positively inclined.\u00a0\u00a0<\/p>\n<p>Much is riding on vaccine rollouts in the U.K. and beyond. The U.K. government has recently set out a four-step plan to lift a national lockdown in England over the coming weeks and months, but has said it would rely on data rather than dates in determining how and when it lifts restrictions. How quickly it can re-open public life will affect how quickly its economy, which contracted almost 10% in 2020, can bounce back.<\/p>\n<p>Ben Ansell,\u00a0professor of Comparative Democratic Institutions\u00a0at the Department of Politics and International Relations at Oxford University, said the findings showed &quot;important gaps remain especially among groups whose trust in politicians is typically lower: non-voters, younger citizens, and poorer households.&quot;<\/p>\n<p>&quot;When so much of the U.K. Government&#x27;s\u00a0lockdown exit strategy rests on successful vaccine roll out, these insights\u00a0will be of immediate importance to policymakers in both their internal deliberation\u00a0on policy and their outward facing communication with the public.&quot;<\/p>\n<p>The Economist Intelligence Unit has forecast that, if vaccine rollouts proceed as it currently expects, most developed countries should have immunized 60-70% of their population by mid-2022. It believes the economic impact of vaccination rollouts should emerge sooner, however, with a global economic recovery to pick up pace from mid\u20112021.<\/p>\n<p>Source: <a href=\"https:\/\/www.cnbc.com\/2021\/02\/24\/public-support-for-covid-vaccines-rises-but-skepticism-remains-study.html\" target=\"_blank\" rel=\"noopener noreferrer\">Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>More than three quarters of people in the U.K. now say they are &quot;very likely&quot; to have a coronavirus vaccine, a survey by the University [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":107869,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds - Fin2me\" \/>\n<meta property=\"og:description\" content=\"More than three quarters of people in the U.K. now say they are &quot;very likely&quot; to have a coronavirus vaccine, a survey by the University [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-24T15:51:46+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/02\/cfntalkfoto106836136-1612533725911-gettyimages-1230968914-AFP_9292RY.jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/\",\"url\":\"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/\",\"name\":\"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-02-24T15:51:46+00:00\",\"dateModified\":\"2021-02-24T15:51:46+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business\",\"item\":\"https:\/\/fin2me.com\/category\/business\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/","og_locale":"en_US","og_type":"article","og_title":"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds - Fin2me","og_description":"More than three quarters of people in the U.K. now say they are &quot;very likely&quot; to have a coronavirus vaccine, a survey by the University [...]","og_url":"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/","og_site_name":"Fin2me","article_published_time":"2021-02-24T15:51:46+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/02\/cfntalkfoto106836136-1612533725911-gettyimages-1230968914-AFP_9292RY.jpeg","twitter_misc":{"Written by":"Mark","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/","url":"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/","name":"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-02-24T15:51:46+00:00","dateModified":"2021-02-24T15:51:46+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/business\/major-rise-in-public-support-for-covid-vaccines-but-doubts-remain-uk-study-finds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Business","item":"https:\/\/fin2me.com\/category\/business\/"},{"@type":"ListItem","position":3,"name":"&#x27;Major rise&#x27; in public support for Covid vaccines but doubts remain, UK study finds"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/107870"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=107870"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/107870\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/107869"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=107870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=107870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=107870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}